SEC
AGN

Seven Eight Capital’s Allergan plc AGN Stock Holding History

Seven Eight Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,300
Closed -$2.18M – 629
2020
Q1 		$2.18M Sell
12,300
-34,429
-74% -$6.48M 0.56% 46
2019
Q4 		$8.93M Buy
46,729
+14,600
+45% +$2.63M 0.47% 41
2019
Q3 		$5.41M Sell
32,129
-69,671
-68% -$11.4M 0.29% 98
2019
Q2 		$17M Buy
101,800
+33,300
+49% +$4.61M 0.9% 10
2019
Q1 		$10M Buy
68,500
+33,300
+95% +$4.83M 0.53% 49
2018
Q4 		$4.71M Buy
+35,200
New +$5.77M 0.26% 115
2018
Q1 		– Sell
-42,600
Closed -$6.97M – 603
2017
Q4 		$6.97M Buy
42,600
+10,900
+34% +$1.96M 0.71% 30
2017
Q3 		$6.5M Buy
+31,700
New +$7.37M 0.79% 15
2016
Q4 		– Sell
-5,200
Closed -$1.2M – 671
2016
Q3 		$1.2M Buy
+5,200
New +$1.27M 0.35% 98
2016
Q2 		– Sell
-8,800
Closed -$2.36M – 718
2016
Q1 		$2.36M Buy
+8,800
New +$2.52M 1% 2
2014
Q3 		– Sell
-5,262
Closed -$1.17M – 721
2014
Q2 		$1.17M Buy
+5,262
New +$1.09M 1.13% 1

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Seven Eight Capital's AGN Position: Q2 2020 in Review

Seven Eight Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 12,300 shares — an estimated $2.18M sold.

Seven Eight Capital first reported a position in AGN in Q2 2014 and held it in 11 quarters. The position peaked at $17M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Seven Eight Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Seven Eight Capital sold 12,300 Allergan plc shares in Q2 2020, an estimated $2.18M.
  • Seven Eight Capital first reported a position in Allergan plc in Q2 2014 and held it in 11 quarters.
  • Seven Eight Capital's Allergan plc position peaked at $17M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.